Database Query Results : , , PUMA
PUMA, p53 upregulated modulator of apoptosis: Click to Expand ⟱
| Source: |
| Type: pro-apoptotic protein |
The expression of PUMA is regulated by the tumor suppressor p53.
PUMA serves as an important proapoptotic factor that functions as a tumor suppressor by facilitating the elimination of damaged or aberrant cells. In many cancers, impaired induction of PUMA—often due to p53 dysfunction—correlates with treatment resistance and aggressive disease.
|
Scientific Papers found: Click to Expand⟱
*antiOx↑, *Inflam↑, *ROS↓, Apoptosis↑, TumCP↓, BioAv↓, Half-Life↓, eff↑, TumCCA↑, BAX↑, Bak↑, PUMA↑, BIM↑, NOXA↑, TRAIL↑, Bcl-2↓, Bcl-xL↓, survivin↓, XIAP↓, cMyc↓, Casp↑, NF-kB↓, STAT3↓, AP-1↓, angioG↓, TumMeta↑, VEGF↓, MMPs↓, DNMTs↓, HDAC↓, ROS↑,
Bcl-2↓, MMP↓, cl‑Casp3↑, BAX↑, BIM↑, p‑PARP↑, PUMA↑, p‑P53↑, ROS↑, p‑ERK↑, p‑eIF2α↑, CHOP↑, ATF4↑,
*BioAv↓, antiOx↓, Inflam↓, TumCP↓, TumCCA↑, cycD1/CCND1↓, cycE/CCNE↓, P53↑, P21↑, COX2↓, NF-kB↓, Akt↑, NOTCH↓, CDK2↓, CDK6↓, JAK↓, STAT3↓, EGFR↓, p‑ERK↓, p‑Akt↓, p‑STAT3↓, TGF-β↓, SMAD3↓, CDK6↓, Wnt/(β-catenin)↓, Myc↓, survivin↓, CDK8↓, PKCδ↓, tumCV↓, RadioS↑, eff↑, MDM2↓, XIAP↓, p‑RB1↓, PTEN↑, p‑FAK↓, Bax:Bcl2↑, Bcl-xL↓, Mcl-1↓, PUMA↑, NOXA↑, MMP↓, Cyt‑c↑, ROS↑, Ca+2↝, Endoglin↑, Diablo↑, AIF↑, iNOS↓, Casp9↑, Casp3↑, cl‑PARP↑, RadioS↑, Hif1a↓, HO-1↓, HO-2↓, SIRT1↓, selectivity↑, Dose∅, NHE1↓, Glycolysis↓, GlucoseCon↓, lactateProd↓, PDK1?, PDK1?, ECAR↝, COX1↓, Snail↓, Twist↓, cMyc↓, Telomerase↓, angioG↓, MMP2↓, MMP9↓, VEGF↓, Dose↝, PD-L1↓, eff↑, SIRT6↑, DNAdam↓,
tyrosinase↓, CK2↓, TumCP↓, TumCMig↓, FGF↓, FGFR1↓, PI3K↓, Akt↓, VEGF↓, FGFR1↓, FGFR2↓, PDGF↓, ALAT↓, AST↓, TumCCA↑, CDK2↓, CDK4↓, CDK6↓, BAX↓, Bcl-2↓, MMP2↓, MMP9↓, P53↑, PARP↑, PUMA↑, NOXA↑, Casp3↑, Casp9↑, TIMP1↑, lipid-P↑, mtDam↑, EMT↓, Vim↓, E-cadherin↓, p‑STAT3↓, COX2↓, CDC25↓, RadioS↑, ROS↑, DNAdam↑, γH2AX↑, PTEN↑, LC3II↓, Beclin-1↓, SOD↓, Catalase↓, GPx↓, Fas↑, *BioAv↓, cMyc↓, Beclin-1↑, LC3‑Ⅱ/LC3‑Ⅰ↓,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Lung, |
PC9 |
|
|
|
AntiCan↑, TumCMig↓, GSH↓, Casp3↑, Apoptosis↑, ROS↑, HDAC1↓, Ac-histone H3↑, PUMA↑, BAX↑, PCNA↓, Bcl-2↓,
Apoptosis↑, TumCMig↓, TumCCA↑, TumCP↓, angioG↓, P21↑, p27↑, CDK1↓, p‑CDK1↓, cycA1/CCNA1↓, CycB/CCNB1↓, P70S6K↓, CLDN2↓, HK2↓, PFK↓, PKM2↓, LDHA↓, TLR4↓, H3↓, α-tubulin↓, ROS↑, Akt↓, GSK‐3β↓, FOXO3↓, NF-kB↓, cycD1/CCND1↓, MMP↓, ROS↑, i-Ca+2↑, lipid-P↑, ER Stress↑, UPR↑, PERK↑, eIF2α↑, GRP78/BiP↑, BAX↑, PUMA↑, ROS↑, MMP↓, Cyt‑c↑, cl‑Casp8↑, cl‑Casp8↑, cl‑Casp3↑, cl‑PARP↑, eff↑, eff↑, RadioS↑, ChemoSen↑, eff↑,
selectivity↑, eff↑, ROS↑, toxicity↑, GSH↓, GSSG↑, *GSSG∅, cl‑PARP↑, PUMA↑, GSTP1/GSTπ↓, ChemoSen↑,
chemoPv↑, SIRT1↑, Hif1a↓, VEGF↓, STAT3↓, NF-kB↓, COX2↓, PI3K↓, mTOR↓, NRF2↑, NLRP3↓, H2O2↑, ROS↑, P53↑, PUMA↑, BAX↑,
| - |
in-vitro, |
GBM, |
A172 |
|
|
|
- |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
L929 |
|
|
|
*BioAv↑, selectivity↑, AntiCan↑, Apoptosis↑, CHOP↑, GADD34↑, BIM↑, PUMA↑, Ca+2↝,
Dose↝, eff↝, IL1β↓, IL6↓, IL12↓, TNF-α↓, COX2↓, CXCR4↓, MPO↓, HSP70/HSPA5↓, HSP90↓, VCAM-1↓, IKKα↓, NF-kB↓, HO-1↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, cl‑PARP↑, Cyt‑c↑, Diablo↑, CHOP↑, survivin↓, XIAP↓, p38↑, Fas↑, PUMA↑, VEGF↓, Hif1a↓, Twist↓, Zeb1↓, Vim↓, MMP2↓, MMP9↓, E-cadherin↑, N-cadherin↓, Snail↓, CD44↓, cycD1/CCND1↓, cycA1/CCNA1↓, CycB/CCNB1↓, cycE/CCNE↓, CDK4↓, CDK6↓, p50↓, P53↑, P21↑, GSH↑, SOD↑, GSTs↑, mTOR↓, Akt↓, PI3K↓, β-catenin/ZEB1↓, IGF-1↓, cMyc↓, CSCs↓,
| - |
in-vitro, |
Pca, |
22Rv1 |
|
|
|
- |
in-vitro, |
Pca, |
LNCaP |
|
|
|
tumCV↓, Apoptosis↓, P53↑, P21↑, PUMA↑, NOXA↑, MDM2↓, XIAP↓,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 11
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned ⓘ
chemoPv↑, 1,
Redox & Oxidative Stress ⓘ
antiOx↓, 1, Catalase↓, 1, GPx↓, 1, GSH↓, 2, GSH↑, 1, GSSG↑, 1, GSTP1/GSTπ↓, 1, GSTs↑, 1, H2O2↑, 1, HO-1↓, 1, HO-1↑, 1, HO-2↓, 1, lipid-P↑, 2, MPO↓, 1, NRF2↑, 1, ROS↑, 10, SOD↓, 1, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
AIF↑, 1, CDC25↓, 1, FGFR1↓, 2, MMP↓, 4, mtDam↑, 1, XIAP↓, 4,
Core Metabolism/Glycolysis ⓘ
Ac-histone H3↑, 1, ALAT↓, 1, cMyc↓, 4, ECAR↝, 1, GlucoseCon↓, 1, Glycolysis↓, 1, HK2↓, 1, lactateProd↓, 1, LDHA↓, 1, PDK1?, 2, PFK↓, 1, PKM2↓, 1, SIRT1↓, 1, SIRT1↑, 1,
Cell Death ⓘ
Akt↓, 3, Akt↑, 1, p‑Akt↓, 1, Apoptosis↓, 1, Apoptosis↑, 4, Bak↑, 1, BAX↓, 1, BAX↑, 5, Bax:Bcl2↑, 1, Bcl-2↓, 4, Bcl-xL↓, 2, BIM↑, 3, Casp↑, 1, Casp3↑, 4, cl‑Casp3↑, 2, Casp7↑, 1, Casp8↑, 1, cl‑Casp8↑, 2, Casp9↑, 3, CK2↓, 1, Cyt‑c↑, 3, Diablo↑, 2, Fas↑, 2, GADD34↑, 1, iNOS↓, 1, Mcl-1↓, 1, MDM2↓, 2, Myc↓, 1, NOXA↑, 4, p27↑, 1, p38↑, 1, PUMA↑, 11, survivin↓, 3, Telomerase↓, 1, TRAIL↑, 1,
Transcription & Epigenetics ⓘ
H3↓, 1, tumCV↓, 2,
Protein Folding & ER Stress ⓘ
CHOP↑, 3, eIF2α↑, 1, p‑eIF2α↑, 1, ER Stress↑, 1, GRP78/BiP↑, 1, HSP70/HSPA5↓, 1, HSP90↓, 1, PERK↑, 1, UPR↑, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↓, 1, Beclin-1↑, 1, LC3‑Ⅱ/LC3‑Ⅰ↓, 1, LC3II↓, 1,
DNA Damage & Repair ⓘ
DNAdam↓, 1, DNAdam↑, 1, DNMTs↓, 1, P53↑, 5, p‑P53↑, 1, PARP↑, 1, p‑PARP↑, 1, cl‑PARP↑, 4, PCNA↓, 1, SIRT6↑, 1, γH2AX↑, 1,
Cell Cycle & Senescence ⓘ
CDK1↓, 1, p‑CDK1↓, 1, CDK2↓, 2, CDK4↓, 2, cycA1/CCNA1↓, 2, CycB/CCNB1↓, 2, cycD1/CCND1↓, 3, cycE/CCNE↓, 2, P21↑, 4, p‑RB1↓, 1, TumCCA↑, 4,
Proliferation, Differentiation & Cell State ⓘ
CD44↓, 1, CDK8↓, 1, CSCs↓, 1, EMT↓, 1, p‑ERK↓, 1, p‑ERK↑, 1, FGF↓, 1, FGFR2↓, 1, FOXO3↓, 1, GSK‐3β↓, 1, HDAC↓, 1, HDAC1↓, 1, IGF-1↓, 1, mTOR↓, 2, NOTCH↓, 1, P70S6K↓, 1, PI3K↓, 3, PTEN↑, 2, STAT3↓, 3, p‑STAT3↓, 2, tyrosinase↓, 1, Wnt/(β-catenin)↓, 1,
Migration ⓘ
AP-1↓, 1, Ca+2↝, 2, i-Ca+2↑, 1, CLDN2↓, 1, E-cadherin↓, 1, E-cadherin↑, 1, p‑FAK↓, 1, MMP2↓, 3, MMP9↓, 3, MMPs↓, 1, N-cadherin↓, 1, PDGF↓, 1, PKCδ↓, 1, SMAD3↓, 1, Snail↓, 2, TGF-β↓, 1, TIMP1↑, 1, TumCMig↓, 3, TumCP↓, 4, TumMeta↑, 1, Twist↓, 2, VCAM-1↓, 1, Vim↓, 2, Zeb1↓, 1, α-tubulin↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 3, ATF4↑, 1, EGFR↓, 1, Endoglin↑, 1, Hif1a↓, 3, VEGF↓, 5,
Barriers & Transport ⓘ
NHE1↓, 1,
Immune & Inflammatory Signaling ⓘ
COX1↓, 1, COX2↓, 4, CXCR4↓, 1, IKKα↓, 1, IL12↓, 1, IL1β↓, 1, IL6↓, 1, Inflam↓, 1, JAK↓, 1, NF-kB↓, 5, p50↓, 1, PD-L1↓, 1, TLR4↓, 1, TNF-α↓, 1,
Protein Aggregation ⓘ
NLRP3↓, 1,
Hormonal & Nuclear Receptors ⓘ
CDK6↓, 4,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, ChemoSen↑, 2, Dose↝, 2, Dose∅, 1, eff↑, 7, eff↝, 1, Half-Life↓, 1, RadioS↑, 4, selectivity↑, 3,
Clinical Biomarkers ⓘ
ALAT↓, 1, AST↓, 1, EGFR↓, 1, IL6↓, 1, Myc↓, 1, PD-L1↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 2, toxicity↑, 1,
Total Targets: 199
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, GSSG∅, 1, ROS↓, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↑, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, BioAv↑, 1,
Total Targets: 6
Scientific Paper Hit Count for: PUMA, p53 upregulated modulator of apoptosis
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:430 State#:0 Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page